Monthly Archives: December 2023

Class 4 Medicines Defect Information: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) Drug alert number: EL(23)A/43 Date issued: 13 December 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) Company name: Atnahs [...]

The post Class 4 Medicines Defect Information: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) appeared first on Community Pharmacy England.

Update – 19th December 2023 – There has been an update to the process, below, that the PAT will follow. The NHS Business Services Authority (NHSBSA) Provider Assurance Team (PA Team) will soon start to undertake provider assurance work with pharmacy owners providing the Lateral Flow Devices (LFD) test supply service. The reviews, commissioned by [...]

The post Update – LFD service: Provider Assurance activity begins appeared first on Community Pharmacy England.

NHS England has published its vaccination strategy, on which it consulted with stakeholders and the public in the autumn of last year. Read the vaccination strategy A key proposal within the strategy is to delegate commissioning responsibility for vaccination services, which currently rests with NHS England, to integrated care boards (ICB). This follows similar delegation [...]

The post NHS England publishes vaccination strategy appeared first on Community Pharmacy England.

Pharmacy press This  year, 3,511 community pharmacies are delivering COVID vaccines as part of the autumn booster programme. This is more than double the number that took part last year, despite the reduction in the fees paid. Our Director of NHS Services, Alastair Buxton, said: “The participation of nearly a third of community pharmacies in [...]

The post Nearly a third of pharmacies participating in COVID vaccination programme appeared first on Community Pharmacy England.

National Patient Safety Alert: Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba®) products National Patient Safety Alert Reference Number: NatPSA/2023/016/DHSC Date issued: 8th December 2023 Brief description of the problem A Medicine Supply Notification issued on 24 May 2023, detailed a shortage of Tresiba® (insulin degludec) FlexTouch® 100units/ml solution for injection 3ml [...]

The post National Patient Safety Alert: Potential for inappropriate dosing of insulin when switching insulin degludec (Tresiba®) products appeared first on Community Pharmacy England.